The Corvia Atrial Shunt is a novel heart failure (HF) therapy specifically designed to reduce the symptoms associated with high pressures in the heart and lungs. It is the world’s first atrial shunt intended to reduce heart failure hospitalizations and improve quality of life.

Corvia Medical’s leadership team is comprised of professionals who share a passion and commitment to transform the standard of care for heart failure treatment. Each member of the management team brings extensive experience within the medical device field and a track record of success.